Health-care software vendor Athenahealth on Tuesday said it will offer Abridge’s artificial intelligence scribing tool to its network of more than 160,000 clinicians. 

Athenahealth has developed an electronic health record, revenue cycle management tools and patient engagement tools for ambulatory care providers, which include outpatient facilities like independent practices. The company introduced a solution called Ambient Notes in October that allows doctors to choose between various AI-powered documentation tools, and Abridge is the latest addition. 

Abridge uses AI to draft clinical notes in real time as doctors consensually record their visits with patients. The startup is part of a red-hot market that has exploded as health-care executives search for solutions to help reduce staff burnout and daunting administrative workloads. 

“The market is going to evolve rather rapidly, there are going to be winners and losers over time,” Athenahealth CEO Bob Segert told CNBC. “Different physicians will prefer different ways that notes are taken and that the information is delivered, and we want to be able to provide that flexibility.”

Athenahealth and Abridge declined to share the financial details of the partnership. 

Clinicians spend nearly nine hours a week on documentation, according to an October study from Google Cloud. And more than 90% of physicians report feeling burned out on a “regular basis,” according to a survey commissioned by Athenahealth last February. 

Companies including Abridge, Microsoft’s Nuance Communications, Suki and others say their AI scribing tools can help. Suki and iScribeHealth already offer their tools through Athenahealth’s Ambient Notes solution. 

“It’ll be incumbent upon us to make sure that we’re able to demonstrate differentiation,” Abridge CEO Dr. Shiv Rao told CNBC. “So far, we’ve had good luck these last few years doing that.”

Abridge has deployed its technology across more than 100 health systems in the U.S., including organizations like the Mayo Clinic, Duke Health and Johns Hopkins Medicine.

The company announced a $250 million funding round earlier this month. It also unveiled a new Contextual Reasoning Engine that can pull information that’s relevant to a specific clinician and their clinic’s best practices. Abridge’s Rao said that technology will be available to Athenahealth clinicians. 

Athenahealth’s Ambient Notes solution is currently available in a limited capacity, but the company said it plans to widen availability for clinicians through 2025. 

“The more they try it, the more they like it, and I think we’re going to see a pretty steep adoption curve as this continues to move forward,” Segert said.

Bitcoin fell through the $90,000 level overnight, weakened by sell pressure in equities as the crypto market awaits its next catalyst.

The price of bitcoin fell 6% to $88,519, according to Coin Metrics. Earlier, it fell as low as $87,736.

The decline puts the blue chip coin almost 20% off its all-time high reached on President Donald Trump’s inauguration day.

“Equities have faced a few difficult sessions over the last week, with top-performing stocks down many times the index, as markets grapple with increased uncertainty under the new administration,” said Steven Lubka, head of private clients and family offices at Swan Bitcoin. “This pressure has spilled over into bitcoin and crypto markets.”

The S&P 500 on Monday posted a three-day losing streak as it failed to recover from last week’s sell-off, driven by concern over a slowing economy and sticky inflation.

“Ultimately, the lack of visible short-term catalysts and pressure from equities creates an environment for profit-taking and pressure from shorts,” Lubka added.

Bitcoin kicked off the year in rally mode, fueled by optimism about the positive changes the new Trump administration was expected to make for the crypto industry. However, since the President issued his widely anticipated executive order on crypto at the end of January – the contents of which were well received by the industry despite its tamer than hoped for language on a strategic bitcoin reserve – the market has had little to look forward to.

While optimism about the long-term positive impact Trump’s policies could have for crypto remains high, its movements have been and may continue to be dictated by macroeconomic trends.

“From November through January, the market was very enthusiastic about pricing in a crypto-friendly U.S. administration,” said Joel Kruger, market strategist at LMAX Group. “Now it’s a question of waiting for that next catalyst. We know that all of this is in place, and the market is in a bit of a sell-the-fact consolidation sell as it kind of waits.”

The $90,000 level marks the bottom of the narrow range bitcoin has been trading in since the end of November. Analysts have warned that if bitcoin were to meaningfully break below the level, it could see a deeper pullback toward $80,000.

“There is room for bitcoin still to go back down towards the $70,000 to $75,000 area without doing anything to compromise the outlook,” Kruger said, “and we suspect that there will be plenty of demand as we head down towards those levels.”

Lubka said he believes bitcoin will finish digesting this move and resume its long-term move higher by mid-March.

Other cryptocurrencies fared worse on Monday. Ether and Solana’s sol token each tumbled 9%. The broader market of cryptocurrencies, as measured by the CoinDesk 20 index, lost more than 8%.